... a clinical-stage biotechnology company developing optogenetic gene ... Research at Medical Center Ophthalmology Associates in San Antonio.
News
- Nanoscope Therapeutics' Optogenetic Gene Therapy to be Featured in ... - Star Local Media
- Texas Biomed launching major SA campus expansion - San Antonio Business Journal
Texas Biomedical Research Institute and the Southwest National Primate Research Center plan to build four new buildings that will house primates, ...
- SynDevRx To Present Pre-Clinical Combination Data of Evexomostat (SDX-7320) with ...
... Capivasertib (AZD-5363) at 2021 San Antonio Breast Cancer Symposium. ... 2021--(BUSINESS WIRE)--SynDevRx, Inc., a clinical-stage biotechnology ...
- Datopotamab deruxtecan continues to show promise in breast cancer - The Pharma Letter
These data were featured during an oral presentation (GS1-05) at the 2021 San Antonio Breast Cancer Symposium. Daiichi Sankyo's shares closed up ...
- Positive EMERALD Trial Results for Elacestrant Presented at San Antonio Breast ... - BioSpace
Positive EMERALD Trial Results for Elacestrant Presented at San Antonio Breast Cancer Symposium 2021 - read this article along with other careers ...